Accessibility Menu
Bicycle Therapeutics Plc Stock Quote

Bicycle Therapeutics Plc (NASDAQ: BCYC)

$7.91
(0.4%)
+0.03
Price as of October 23, 2025, 11:55 a.m. ET

KEY DATA POINTS

Current Price
$7.91
Daily Change
(0.4%) +$0.03
Day's Range
$7.69 - $7.96
Previous Close
$7.88
Open
$7.88
Beta
1.09
Volume
70,013
Average Volume
279,244
Market Cap
393M
Market Cap / Employee
$7.88M
52wk Range
$6.1 - $25.77
Revenue
-
Gross Margin
0.63%
Dividend Yield
N/A
EPS
-$3.52
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Bicycle Therapeutics Plc Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
BCYC-69.94%-58.5%-16.13%-34%
S&P+14.5%+93.32%+14.09%+137%

Bicycle Therapeutics Plc Company Info

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$2.95M-68.5%
Gross Profit$1.24M-84.0%
Gross Margin41.92%-40.6%
Market Cap$480.96M-44.3%
Market Cap / Employee$1.58M0.0%
Employees3057.4%
Net Income-$79.89M-100.4%
EBITDA-$98.33M-87.4%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$721.45M-25.0%
Accounts Receivable$0.14M0.0%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$2.55M-83.2%
Short Term Debt$5.43M-80.2%

Ratios

Q2 2025YOY Change
Return On Assets-25.78%-3.9%
Return On Invested Capital-33.05%2.3%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$74.33M-64.7%
Operating Free Cash Flow-$73.82M-65.1%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book1.881.160.740.65-73.20%
Price to Sales42.2327.4122.8024.88-6.41%
Price to Tangible Book Value1.881.160.740.65-73.20%
Enterprise Value to EBITDA-9.65-1.262.522.36-192.67%
Return on Equity-26.8%-29.1%-37.1%-31.6%4.33%
Total Debt$11.09M$9.49M$9.12M$7.99M-81.31%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.